
OraSure Technologies Inc is a US-based company that specializes in developing and manufacturing diagnostic and collection devices. The company was founded in 1992 by Douglas A. Michels.
OraSure Technologies has a diverse product portfolio, including rapid tests for infectious diseases, such as HIV and COVID-19. Its products are used in various settings, including healthcare facilities, clinics, and community health organizations.
The company is headquartered in Bethlehem, Pennsylvania, and has a global presence with operations in over 40 countries.
Discover more: Cassa Centrale Banca - Credito Cooperativo Italiano
Products and Services
OraSure Technologies offers a range of products, but one of their most notable is the OraQuick test.
The OraQuick test can detect the presence of HIV from a mouth swab within 20 minutes.
It was created by OraSure and began being marketed to healthcare practitioners in 2004.
The test was found to be 93 percent accurate in detecting HIV in those carrying the disease in a trial conducted by OraSure.
However, this rate falls below the FDA-recommended 95 percent threshold for accuracy.
On the other hand, the test was more accurate at clearing patients who didn't have the disease, correctly identifying HIV-negative users 99 percent of the time.
In July 2012, the FDA approved OraQuick for over-the-counter use.
Competitor Analysis
OraSure Technologies has some notable competitors in the industry. OraSure Technologies Inc is headquartered in the United States of America, specifically in Bethlehem, Pennsylvania.
The company's size is also a point of interest, with 501 employees on board. This is relatively small compared to some of its competitors, such as Zoetis Inc, which has 13,800 employees.
Here's a brief overview of the competitors mentioned in the table:
Competitor Comparison
Competitor Comparison is a crucial aspect of any business, and in this case, we're analyzing the key parameters of five competitors in the industry. OraSure Technologies Inc, Zoetis Inc, Trinity Biotech Plc, Psychemedics Corp, and MedMira Inc are all public companies with a significant presence in the market.
Let's start with their headquarters - all five companies are based in the United States or Canada, with OraSure and Zoetis having their headquarters in the United States of America.
Here's a breakdown of their key parameters:
These numbers give us a sense of the scale and scope of each company, with Zoetis Inc being the largest in terms of employee count.
Sherlock Biosciences

Sherlock Biosciences is a global health company that develops next-generation diagnostics for consumers and healthcare providers.
Their molecular diagnostics platform provides rapid, highly sensitive, and specific results in a disposable format ideal for over-the-counter use.
Sherlock's first molecular self-test targets Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG), which will broaden OraSure's portfolio of rapid diagnostics for sexually transmitted infections (STIs).
This self-test promises results in under 30 minutes by analyzing DNA and RNA from self-collected swabs using isothermal amplification.
Sherlock is also developing a range of molecular tests and next-generation technology platforms, including Ambient Temperature Amplification and CRISPR-based technologies.
These technologies could lower costs and improve the performance of its diagnostic platforms.
Sherlock's CT/NG self-test is currently undergoing clinical studies and is expected to be submitted to the FDA by the end of 2025 for approval.
The total addressable market for CT/NG testing is estimated at over USD 1.5 billion.
This acquisition is expected to drive OraSure's growth, beginning in 2026, through its established infrastructure, commercial capabilities, and robust customer relationships.
Discover more: Self (company)
Featured Images: pexels.com


